Besides, our results herein revealed that intratumoral p-PAK1 overexpression was predictive of poor clinical outcome of RCC patients following surgery, further suggesting the crucial role of PAK1 hyperactivation in RCC progression. Here, PAK1 is linked to renal cell carcinoma.